Business Categories Reports Podcasts Events Awards Webinars
Contact My Account About


Published November 9, 2020
Published November 9, 2020
via Unsplash Lucas Benjamin

Leading synthetic biotechnology company in clean health and beauty markets Amyris reported its wholly-owned consumer brands delivered 220% growth on a year-to-date basis and product revenue demonstrated three consecutive quarters of >55% YoY growth. This success is fueling the expansion of its beauty brand portfolio beyond Biossance skincare and Pipette baby and mother care in a partnership with Rosie Huntington-Whiteley, model turned businesswoman and founder of beauty commerce destination Rose Inc.

“The formation of Clean Beauty Collaborative demonstrates Amyris’ strong commitment to continuous innovation of the clean beauty category,” said John Melo, President and Chief Executive Officer of Amyris, Inc. “We are very pleased to be partnering with Rosie on this new venture. Rosie and Amyris share a clear vision and commitment to making the Beauty industry better through great performing products that are produced sustainably without harm to our planet. We believe cosmetics to be the next opportunity for us to transform to clean and we are very excited to have Caroline lead the creation of her third brand in the Amyris family of direct-to-consumer beauty.”

The two have created a new company, Clean Beauty Collaborative, to develop a new line of products using the brand Rose Inc. and expand the Rose Inc. content platform. The product range is expected to launch during the third quarter of 2021. Caroline Hadfield, President of Amyris’ clean skincare ingredients business, will be the Chief Executive Officer of Clean Beauty Collaborative, and Rosie Huntington-Whiteley will be Chief Creative Officer.

Rosie Huntington-Whiteley commented, “I am passionate about responsible beauty products that are healthy for people and the planet. Working with Pipette this past year, I have been thoroughly impressed with Amyris’ technology and its leadership in creating sustainable, non-toxic and trustworthy products.”

The Amyris business model balances innovation on the supply side while the creation of consumer brands has proved resilient. In Q3 2020 Amyris reported Product Revenue (Consumer & Ingredients) of $31 million was up 58% compared with the prior year quarter, with year-over-year revenue growth in Consumer (+203%) and Ingredients (+21%).

John Melo said, “The third quarter of 2020 was another strong quarter for our company. Our ability to deliver record Product Revenue in these difficult and uncertain times is a testament to the resiliency of our team, the growing trend of consumers’ commitment to sustainable brands, our products, and the robustness of our business model.”

Mr. Melo added, “During the quarter, we continued to execute across the strategic priorities we laid out in the beginning of the year. Our consumer business is growing at over three times 2019 revenue and delivered significantly expanded Gross Margin. We expect the combination of a strong fourth quarter along with the successful completion of strategic transactions to set us up for a profitable 2021.”


2 Article(s) Remaining

Subscribe today for full access